Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rubraca (rucaparib) for the Treatment of Advanced Ovarian Cancer

Rubraca contains PARP inhibitors for improving progression-free survival in women. Image courtesy of Emw.

Go Top